|
1
|
Dabestani S, Beisland C, Stewart GD,
Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P,
Marconi L, Fernandéz-Pello S, et al: Intensive Imaging-based
follow-up of surgically treated localised renal cell carcinoma does
not improve Post-recurrence survival: Results from a European
multicentre database (RECUR). Eur Urol. 75:261–264. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sheth S, Scatarige JC, Horton KM, Corl FM
and Fishman EK: Current concepts in the diagnosis and management of
renal cell carcinoma: Role of multidetector ct and
Three-dimensional CT. Radiographics. 21 (Suppl):S237–S254. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chappell WH, Steelman LS, Long JM, Kempf
RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone
P, et al: Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:
Rationale and importance to inhibiting these pathways in human
health. Oncotarget. 2:135–1365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elfiky AA, Aziz SA, Conrad PJ, Siddiqui S,
Hackl W, Maira M, Robert CL and Kluger HM: Characterization and
targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian
target of rapamycin (mTOR) in renal cell cancer. J Transl Med.
9:1332011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Cristofano C, Minervini A, Menicagli M,
Salinitri G, Bertacca G, Pefanis G, Masieri L, Lessi F, Collecchi
P, Minervini R, et al: Nuclear expression of hypoxia-inducible
factor-1alpha in clear cell renal cell carcinoma is involved in
tumor progression. Am J Surg Pathol. 31:1875–1881. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li M, Wang Y, Song Y, Bu R, Yin B, Fei X,
Guo Q and Wu B: Expression profiling and clinicopathological
significance of DNA methyltransferase 1, 3A and 3B in sporadic
human renal cell carcinoma. Int J Clin Exp Pathol. 7:7597–609.
2014.PubMed/NCBI
|
|
8
|
Shang D, Liu Y, Ito N, Kamoto T and Ogawa
O: Defective Jak-Stat activation in renal cell carcinoma is
associated with interferon-alpha resistance. Cancer Sci.
98:1259–1264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Von Schulz-Hausmann S, Schmeel L, Schmeel
F and Schmidt-Wolf I: Targeting the Wnt/beta-catenin pathway in
renal cell carcinoma. Anticancer Res. 34:4101–4108. 2014.PubMed/NCBI
|
|
10
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vicens Q and Westhof E: Biogenesis of
circular RNAs. Cell. 159:13–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conn S, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
You X, Vlatkovic I, Babic A, Will T,
Epstein I, Tushev G, Akbalik G, Wang M, Glock C, Quedenau C, et al:
Neural circular RNAs are derived from synaptic genes and regulated
by development and plasticity. Nat Neurosci. 18:603–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao Z, Luo J, Hu K, Lin J, Huang H, Wang
Q, Zhang P, Xiong Z, He C, Huang Z, et al: ZKSCAN1 gene and its
related circular RNA (circZKSCAN1) both inhibit hepatocellular
carcinoma cell growth, migration, and invasion but through
different signaling pathways. Mol Oncol. 11:422–437. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tlsty T and Coussens L: Tumor stroma and
regulation of cancer development. Annu Rev Pathol. 1:119–150. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–759. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keller S, Sanderson M, Stoeck A and
Altevogt P: Exosomes: From biogenesis and secretion to biological
function. Immunol. Lett. 107:102–108. 2006.
|
|
19
|
Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X,
Shi L, Lu X, Xu W, Lu L, et al: STAT3-regulated exosomal miR-21
promotes angiogenesis and is involved in neoplastic processes of
transformed human bronchial epithelial cells. Cancer Lett.
370:125–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilusz J and Sharp P: Molecular biology. A
circuitous route tononcoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang PF, Wei CY, Huang XY, Peng R, Yang
X, Lu JC, Zhang C, Gao C, Cai JB, Gao PT, et al: Circular RNA
circTRIM33-12 acts as the sponge of microRNA-191 to suppress
hepatocellular carcinoma progression. Mol Cancer. 18:1052019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dou Y, Cha DJ, Franklin JL, Higginbotham
JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG
and Zhang B: Circular RNAs are Down-regulated in KRAS mutant colon
cancer cells and can be transferred to exosomes. Sci Rep.
6:379822016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee J and Lötvall J: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using Real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao A, Li G, Péoc'h M, Genin C and
Gigante M: Serum miR-210 as a novel biomarker for molecular
diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol.
94:115–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Han Y, Zhang H, Nie L, Jiang Z, Fa
P and Gui Y: Synthetic miRNA-mowers targeting miR-183-96-182
cluster or miR-210 inhibit growth and migration and induce
apoptosis in bladder cancer cells. PLoS One. 7:e522802012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakada C, Tsukamoto Y, Matsuura K, Nguyen
TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M and Moriyama M:
Overexpression of miR-210, a downstream target of HIF1a, causes
centrosome amplification in renal carcinoma cells. J Pathol.
224:280–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Favaro E, Ramachandran A, McCormick R, Gee
H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, et al:
MicroRNA-210 regulates mitochondrial free radical response to
hypoxia and Krebs cycle in cancer cells by targeting iron sulfur
cluster protein ISCU. PLoS One. 5:e103452010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen WY, Liu WJ, Zhao YP, Zhou L, Zhang
TP, Chen G and Shu H: Induction, modulation and potential targets
of miR-210 in pancreatic cancer cells. Hepatobiliary Pancreat Dis
Int. 11:319–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tobelaim W, Beaurivage C, Champagne A,
Pomerleau V, Simoneau A, Chababi W, Yeganeh M, Thibault P, Klinck
R, Carrier JC, et al: Tumour-promoting role of SOCS1 in colorectal
cancer cells. Sci Rep. 5:143012015. View Article : Google Scholar : PubMed/NCBI
|
